1. Home
  2. LSB vs EICA Comparison

LSB vs EICA Comparison

Compare LSB & EICA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSB
  • EICA
  • Stock Information
  • Founded
  • LSB 2002
  • EICA N/A
  • Country
  • LSB China
  • EICA
  • Employees
  • LSB N/A
  • EICA N/A
  • Industry
  • LSB
  • EICA Finance/Investors Services
  • Sector
  • LSB
  • EICA Finance
  • Exchange
  • LSB NYSE
  • EICA Nasdaq
  • Market Cap
  • LSB 22.3M
  • EICA N/A
  • IPO Year
  • LSB N/A
  • EICA 2021
  • Fundamental
  • Price
  • LSB $1.10
  • EICA $24.54
  • Analyst Decision
  • LSB
  • EICA
  • Analyst Count
  • LSB 0
  • EICA 0
  • Target Price
  • LSB N/A
  • EICA N/A
  • AVG Volume (30 Days)
  • LSB 818.1K
  • EICA N/A
  • Earning Date
  • LSB 07-22-2025
  • EICA N/A
  • Dividend Yield
  • LSB N/A
  • EICA N/A
  • EPS Growth
  • LSB N/A
  • EICA N/A
  • EPS
  • LSB N/A
  • EICA N/A
  • Revenue
  • LSB $79,415,311.00
  • EICA N/A
  • Revenue This Year
  • LSB $39.33
  • EICA N/A
  • Revenue Next Year
  • LSB $75.61
  • EICA N/A
  • P/E Ratio
  • LSB N/A
  • EICA N/A
  • Revenue Growth
  • LSB N/A
  • EICA N/A
  • 52 Week Low
  • LSB $0.36
  • EICA N/A
  • 52 Week High
  • LSB $6.82
  • EICA N/A
  • Technical
  • Relative Strength Index (RSI)
  • LSB 50.39
  • EICA 62.20
  • Support Level
  • LSB $0.93
  • EICA $24.40
  • Resistance Level
  • LSB $1.48
  • EICA $24.63
  • Average True Range (ATR)
  • LSB 0.11
  • EICA 0.07
  • MACD
  • LSB 0.03
  • EICA 0.03
  • Stochastic Oscillator
  • LSB 30.51
  • EICA 77.00

About LSB LAKESHORE BIOPHARMA CO LTD

LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.

About EICA Eagle Point Income Company Inc. 5.00% Series A Term Preferred Stock due 2026

Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or "CLOs," that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.

Share on Social Networks: